Clinical trial
Optimization of Acute Treatment in First Episode Schizophrenia
NCT00157378 · Ludwig-Maximilians - University of Munich, Other · Unknown status
Key facts
| NCT number | NCT00157378 |
|---|---|
| Title | Optimization of Acute Treatment in First Episode Schizophrenia |
| Official title | Optimization of Acute Treatment in First Episode Schizophrenic Patients by New Pharmacological Treatments |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Collaborators | Janssen-Cilag Ltd. Industry German Research Network On Schizophrenia Department of Psychiatry University of Bonn Heinrich-Heine University, Duesseldorf Department of Psychiatry University FU Berlin… |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, First-Episode |
| Intervention type | Drug |
| Interventions | Risperidone, Haloperidol |
| Enrollment | 300 |
| Start date | Nov 1, 2000 |
| Completion | Dec 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: